{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:56:08Z","timestamp":1790610968293,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14453-6","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:55:18Z","timestamp":1789736118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid profile alterations in pulmonary tuberculosis patients with and without diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Samuel","family":"Yahaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Anyass","family":"Goumboundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Osei","family":"Saahene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwabena","family":"Dankwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K. D.","family":"Ephraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"14453_CR1","unstructured":"World Health Organization. Global tuberculosis report 2025 [Internet]. 2025. https:\/\/iris.who.int\/. 13 Jul 2026."},{"key":"14453_CR2","unstructured":"International Diabetes Federation. The diabetes atlas, 11th edition [Internet]. 2025. https:\/\/diabetesatlas.org\/. 13 Jul 2026."},{"key":"14453_CR3","doi-asserted-by":"publisher","unstructured":"Franco JV, Bongaerts B, Metzendorf M-I, Risso A, Guo Y, Pe\u00f1a Silva L, et al. Diabetes as a risk factor for tuberculosis disease. Cochrane Database Systematic Rev. 2024;2025(2). Art. No.: CD016013. https:\/\/doi.org\/10.1002\/14651858.CD016013.pub2.","DOI":"10.1002\/14651858.CD016013.pub2"},{"key":"14453_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fimmu.2020.00910","volume":"11","author":"D Shim","year":"2020","unstructured":"Shim D, Kim H, Shin SJ. Mycobacterium tuberculosis infection-driven foamy macrophages and their implications in tuberculosis control as targets for host-directed therapy. Front Immunol. 2020;11:910. https:\/\/doi.org\/10.3389\/fimmu.2020.00910.","journal-title":"Front Immunol"},{"issue":"10","key":"14453_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00018-023-04914-5","volume":"80","author":"H Kim","year":"2023","unstructured":"Kim H, Shin SJ. Revolutionizing control strategies against mycobacterium tuberculosis infection through selected targeting of lipid metabolism. Cellular Mol Life Sci. 2023;80(10):291. https:\/\/doi.org\/10.1007\/s00018-023-04914-5.","journal-title":"Cellular Mol Life Sci"},{"issue":"1","key":"14453_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1476-511X-11-54","volume":"11","author":"L Tian","year":"2012","unstructured":"Tian L, Long S, Li C, Liu Y, Chen Y, Zeng Z, et al. High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes. Lipids Health Dis. 2012;11(1):54. https:\/\/doi.org\/10.1186\/1476-511X-11-54.","journal-title":"Lipids Health Dis"},{"key":"14453_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","volume":"18","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18:127. https:\/\/doi.org\/10.1007\/s11892-018-1101-6.","journal-title":"Curr Diab Rep"},{"key":"14453_CR8","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.smim.2025.101959","volume":"78","author":"PM Thong","year":"2025","unstructured":"Thong PM, Wong YH, Kornfeld H, Goletti D, Ong CWM. Immune dysregulation of diabetes in tuberculosis. Semin Immunol. 2025;78:101959. https:\/\/doi.org\/10.1016\/j.smim.2025.101959.","journal-title":"Semin Immunol"},{"issue":"1","key":"14453_CR9","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1038\/s41598-020-68443-y","volume":"10","author":"Y Ding","year":"2020","unstructured":"Ding Y, Raterink R-J, Mar\u00edn-Juez R, Veneman WJ, Egbers K, van den Eeden S, et al. Tuberculosis causes highly conserved metabolic changes in human patients, mycobacteria-infected mice and zebrafish larvae. Sci Rep. 2020;10(1):11635. https:\/\/doi.org\/10.1038\/s41598-020-68443-y.","journal-title":"Sci Rep"},{"issue":"11","key":"14453_CR10","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.3390\/microorganisms9112282","volume":"9","author":"MD Ngo","year":"2021","unstructured":"Ngo MD, Bartlett S, Ronacher K. Diabetes-associated susceptibility to tuberculosis: contribution of hyperglycemia vs. dyslipidemia. Microorganisms. 2021;9(11):2282. https:\/\/doi.org\/10.3390\/microorganisms9112282.","journal-title":"Microorganisms"},{"key":"14453_CR11","doi-asserted-by":"publisher","unstructured":"Bahardoust M, Shokohyar S, Maleki F, Shafiee A, Tehrani FM, Ghaffari A. Socioeconomic inequalities and type 2 diabetes comorbidities: a systematic review and meta-analysis on observational studies. Endocrinol Diabetes Metab. 2026;9(1):e70160. https:\/\/doi.org\/10.1002\/edm2.70160.","DOI":"10.1002\/edm2.70160"},{"key":"14453_CR12","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"14453_CR13","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.1038\/s41598-026-36529-8","volume":"16","author":"AB Asare","year":"2026","unstructured":"Asare AB, Asare P, Yeboah-Manu M, Osei-Wusu S, Konadu ED, Asante-Poku A, et al. Patients with tuberculosis and diabetes show altered clinical and biochemical parameters during anti-TB treatment. Sci Rep. 2026;16(1):7266. https:\/\/doi.org\/10.1038\/s41598-026-36529-8.","journal-title":"Sci Rep"},{"issue":"2","key":"14453_CR14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.15562\/bmj.v10i2.2474","volume":"10","author":"A Berbudi","year":"2021","unstructured":"Berbudi A, Camilla C, Rahmadika N, Cahyadi AI, Ruslami R. Comparison of the nutritional status and lipid profile of tuberculosis patients with and without type 2 diabetes mellitus in primary health care in Bandung. Bali Med J. 2021;10(2):910\u20134. https:\/\/doi.org\/10.15562\/bmj.v10i2.2474.","journal-title":"Bali Med J"},{"issue":"1","key":"14453_CR15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","volume":"7","author":"CA Prada-Medina","year":"2017","unstructured":"Prada-Medina CA, Fukutani KF, Pavan Kumar N, Gil-Santana L, Babu S, Lichtenstein F, et al. Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications. Sci Rep. 2017;7(1):1999. https:\/\/doi.org\/10.1038\/s41598-017-01767-4.","journal-title":"Sci Rep"},{"issue":"5","key":"14453_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chest.2017.11.029","volume":"153","author":"Z Dong","year":"2018","unstructured":"Dong Z, Shi J, Dorhoi A, Zhang J, Soodeen-Lalloo AK, Tan W, et al. Hemostasis and lipoprotein indices signify exacerbated lung injury in TB with diabetes comorbidity. Chest. 2018;153(5):1187\u2013200. https:\/\/doi.org\/10.1016\/j.chest.2017.11.029.","journal-title":"Chest"},{"issue":"1","key":"14453_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"14453_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"14453_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12890-025-03669-y","volume":"25","author":"J Gui","year":"2025","unstructured":"Gui J, Wang F, Hong C-Y, Fu Y, Yang H, Cai Y-M. Study on the correlation between oxidized low- density lipoprotein and oxidized high- density lipoprotein with type 2 diabetes complicated by pulmonary tuberculosis. BMC Pulm Med. 2025;25(1):225. https:\/\/doi.org\/10.1186\/s12890-025-03669-y.","journal-title":"BMC Pulm Med"},{"key":"14453_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.05.011","volume":"32","author":"F Vrieling","year":"2018","unstructured":"Vrieling F, Ronacher K, Kleynhans L, van den Akker E, Walzl G, Ottenhoff THM, et al. Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile. EBioMedicine. 2018;32:192\u2013200. https:\/\/doi.org\/10.1016\/j.ebiom.2018.05.011.","journal-title":"EBioMedicine"},{"key":"14453_CR21","volume-title":"Statistical methods for meta-analysis","author":"LV Hedges","year":"1985","unstructured":"Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando: Academic Press; 1985."},{"key":"14453_CR22","unstructured":"Wells GA, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. 2000. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale.\u00a0Accessed 30 April 2026."},{"key":"14453_CR23","unstructured":"Chandana G, Kumar BP. Lipid abnormalities in tuberculosis patients with diabetes mellitus: a hospital-based cross-sectional study. J Clin Diagnostic Res. 2022;16:OC01\u20134."},{"key":"14453_CR24","first-page":"565","volume":"5","author":"S Manikandan","year":"2023","unstructured":"Manikandan S, Settu S, Nagarajan U. Lipid abnormalities in patients with tuberculosis along with diabetes: a prospective study. Int J Acad Med Pharm. 2023;5:565\u20138.","journal-title":"Int J Acad Med Pharm"},{"key":"14453_CR25","first-page":"41","volume":"121","author":"S Pandey","year":"2023","unstructured":"Pandey S, Bajaj S, Goyal VV. Dyslipidemia in patients with tuberculosis and diabetes mellitus. J Indian Med Assoc. 2023;121:41\u20133.","journal-title":"J Indian Med Assoc"},{"key":"14453_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","volume":"41","author":"G Gago","year":"2018","unstructured":"Gago G, Diacovich L, Gramajo H. Lipid metabolism and its implication in mycobacteria-host interaction. Curr Opin Microbiol. 2018;41:36\u201342. https:\/\/doi.org\/10.1016\/j.mib.2017.11.020.","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"14453_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11883-024-01224-4","volume":"26","author":"YA Jamil","year":"2024","unstructured":"Jamil YA, Cohen R, Alameddine DK, Deo SV, Kumar M, Orkaby AR. Cholesterol lowering in older adults: should we wait for further evidence? Curr Atheroscler Rep. 2024;26(9):521\u201336. https:\/\/doi.org\/10.1007\/s11883-024-01224-4.","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"14453_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","volume":"24","author":"ME Haas","year":"2013","unstructured":"Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab. 2013;24(8):391\u20137. https:\/\/doi.org\/10.1016\/j.tem.2013.04.001.","journal-title":"Trends Endocrinol Metab"},{"key":"14453_CR29","doi-asserted-by":"publisher","unstructured":"Van Hemelrijck M, Ulmer H, Nagel G, Peter RS, Fritz J, Myte R, et al. Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60, 000 men and women in Sweden and Austria. PLoS One. 2018;13(6):e0197830. https:\/\/doi.org\/10.1371\/journal.pone.0197830.","DOI":"10.1371\/journal.pone.0197830"},{"key":"14453_CR30","doi-asserted-by":"publisher","first-page":"696517","DOI":"10.3389\/fcvm.2021.696517","volume":"8","author":"V Chidambaram","year":"2021","unstructured":"Chidambaram V, Zhou L, Ruelas Castillo J, Kumar A, Ayeh SK, Gupte A, et al. Higher serum cholesterol levels are associated with reduced systemic inflammation and mortality during tuberculosis treatment independent of body mass index. Front Cardiovasc Med. 2021;8:696517. https:\/\/doi.org\/10.3389\/fcvm.2021.696517.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"14453_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1194\/jlr.R009720","volume":"52","author":"CT Johansen","year":"2011","unstructured":"Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res. 2011;52(2):189\u2013206. https:\/\/doi.org\/10.1194\/jlr.R009720.","journal-title":"J Lipid Res"},{"issue":"6","key":"14453_CR32","doi-asserted-by":"publisher","first-page":"112760","DOI":"10.1016\/j.isci.2025.112760","volume":"28","author":"J Brake","year":"2025","unstructured":"Brake J, Ajie M, Sumpter NA, Koesoemadinata RC, Soetedjo NNM, Santoso P, et al. Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study. iScience. 2025;28(6):112760. https:\/\/doi.org\/10.1016\/j.isci.2025.112760.","journal-title":"iScience"},{"issue":"7","key":"14453_CR33","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/jcm14072154","volume":"14","author":"R Cioboata","year":"2025","unstructured":"Cioboata R, Balteanu MA, Osman A, Vlasceanu SG, Zlatian OM, Mitroi DM, et al. Coinfections in tuberculosis in low- and middle-income countries: epidemiology, clinical implications, diagnostic challenges, and management strategies\u2014a narrative review. J Clin Med. 2025;14(7):2154. https:\/\/doi.org\/10.3390\/jcm14072154.","journal-title":"J Clin Med"},{"issue":"3","key":"14453_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5588\/ijtld.18.0359","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu P, Laurence YV, Alisjahbana B, Ugarte-Gil C, Riza A-L, Walzl G, et al. Point of care HbA 1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries. Int J Tuberc Lung Disease. 2019;23(3):283\u201392. https:\/\/doi.org\/10.5588\/ijtld.18.0359.","journal-title":"Int J Tuberc Lung Disease"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14453-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14453-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:07:18Z","timestamp":1790608038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14453-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14453"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14453-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1727"}}